Andere talen LifeTech Scientific Corporation

Aandelen

1302

KYG548721177

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:09:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,7 ^HKD	-5,03%		+1,19%	-27,66%

11/04	Lifetech Scientific koopt aandelen voor werknemersstimuleringsregeling	MT
04/04	Lifetech Scientific Unit investeert 340 miljoen yuan in gestructureerde deposito's	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Lifetech Scientific Buys Shares For Employee Incentive Scheme	11/04
Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits	04/04
LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development	02/04
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue	28/03
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
LifeTech Scientific Flags Significant Profit Drop in 2023	08/03
Lifetech Scientific Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	08/03
LifeTech Scientific to Grant 174.8 Million Share Options	25/01
LifeTech Scientific Gets Regulatory Nod to Register Peripheral Thrombus Aspiration Catheter	09/11
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results	30-08-23
LifeTech Scientific's H1 Attributable Profit Grows on Higher Revenue	30-08-23
LifeTech Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	30-08-23
China Grants Official Registration Approval for LifeTech Scientific's Surgical Navigation System	21-08-23
Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA	21-08-23
Jenscare Scientific, LifeTech Complete Treatment for Valve Replacement Product; Jenscare Shares Rise 3%	07-08-23
LifeTech Scientific Unit Invests 50 Million Yuan in Structured Deposit Product by Bank of Ningbo	12-07-23
LifeTech Scientific Completes Patient Enrollment for Phase 3 Study of Coronary Scaffold System	10-07-23
Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of IbsÂ®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed	10-07-23
LifeTech Scientific Corporation Announces Publication of the Three-Year Follow-Up Results of FIM Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System	12-04-23
LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022	29-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen LifeTech Scientific Corporation

Aandelen

1302

KYG548721177

Andere talen

Filters